ChartRow logo
Data provided bySource: Twelve Data
MEDP
$653.09+0.75%
as of close, Nov 17, 2026
☾ AH $653.09 +0.75%
PeersILMNNTRACRLRVTYIQVICLR
Share this page

MEDP financial statements

The full income statement, balance sheet, and cash-flow statement for Medpace Holdings Inc. (MEDP), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +22.3%10Y CAGR +21.6%YoY +8.5%
$2.8B TTM$716M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +26.2%10Y CAGR +38.5%YoY +16.7%
$607.1M TTM$165.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +25.4%10Y n/mYoY +23.7%
$517.8M TTM$137.5M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +31.8%10Y n/mYoY +25.4%
$18.03 TTM$4.84 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +22.5%10Y CAGR +23.6%YoY −12.0%
$723M TTM$216.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +0.0%10Y CAGR +17.1%YoY +88.2%
$55.4M TTM$20.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +24.6%10Y CAGR +24.0%YoY −16.6%
$667.6M TTM$196.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −21.7%10Y −5.8%YoY −1.5%
28.7M TTM28.4M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every MEDP chart on Trends →

Shares outstanding (point-in-time)

2024-09 31.1M2024-12 30.5M2025-03 28.7M2025-06 28.1M2025-09 28.2M2025-12 28.4M2026-03 28.6M2026-06 27.9M2026-09 28.0M-10.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue2.53B+20.0%2.11B+11.8%1.89B+29.2%1.46B+27.8%1.14B+23.4%
————814M+25.8%
Selling, general & administrative198M+9.6%180M+11.7%161M+22.8%131M+21.2%108M+17.6%
Amortization of intangibles946K-34.4%1.44M-34.4%2.20M-34.4%3.35M-34.5%5.11M-35.1%
Provision for credit losses29.0K-74.3%113K-96.7%3.42M0.00-100.0%11.0K-93.4%
Operating income535M+19.7%447M+32.7%337M+20.9%279M+40.3%199M+18.9%
Other non-operating income-5.34M-231.6%4.06M+719.2%-655K-109.3%7.07M+111.5%3.34M+182.5%
Pre-tax income542M+14.0%476M+41.8%336M+18.7%283M+40.1%202M+19.8%
Income tax91.3M+27.6%71.5M+35.3%52.9M+41.0%37.5M+87.4%20.0M-13.6%
451M+11.6%404M+43.0%283M+15.3%245M+34.9%182M+25.1%
Net income to common451M+11.6%404M+43.1%283M+15.3%245M+35.2%181M+25.2%
$15.28+21.0%$12.63+42.2%$8.88+22.0%$7.28+51.4%$4.81+25.3%
EPS (basic)$15.64+19.8%$13.06+42.0%$9.20+21.5%$7.57+49.6%$5.06+24.3%
Weighted-avg shares (basic)28.8M-6.8%31.0M+0.8%30.7M-5.1%32.4M-9.7%35.9M+0.6%
Weighted-avg shares (diluted)29.5M-7.8%32.0M+0.5%31.8M-5.4%33.7M-10.7%37.7M-0.0%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
990M-3.8%1.03B+73.3%594M+77.8%334M-51.7%691M+45.9%
Cash & equivalents497M-25.8%669M+172.7%245M+768.4%28.3M-93.9%461M+66.1%
Accounts receivable402M+35.6%296M-0.7%298M+17.8%253M+35.9%186M+15.8%
Prepaid expenses90.5M+42.9%63.4M+26.8%50.0M-4.4%52.3M+21.1%43.2M+23.6%
1.98B-6.0%2.10B+26.8%1.66B+22.5%1.35B-18.5%1.66B+19.4%
Property, plant & equipment131M+6.0%124M+2.5%121M+9.8%110M+17.9%93.2M+9.6%
Operating lease right-of-use118M-8.4%129M-11.2%145M+4.1%139M+7.3%130M+13.8%
Goodwill662M+0.0%662M+0.0%662M+0.0%662M+0.0%662M+0.0%
Intangible assets33.4M-2.8%34.4M-4.0%35.8M-5.8%38.0M-8.1%41.4M-11.0%
Deferred tax assets19.2M-80.8%100M+34.8%74.4M+54.8%48.1M+91.3%25.1M+4589.2%
Other non-current assets21.9M-1.4%22.3M-10.9%25.0M+18.2%21.1M+21.3%17.4M+98.1%
1.34B+21.7%1.10B+19.4%925M+15.1%803M+44.2%557M+26.6%
Accounts payable28.1M-13.5%32.5M+2.1%31.9M-3.6%33.1M+28.8%25.7M-3.3%
Accrued liabilities408M+32.7%308M+5.1%293M+39.4%210M+31.9%159M+18.5%
Deferred revenue854M+20.2%711M+26.9%560M+21.0%463M+34.3%345M+34.8%
Short-term & current debt——0.00-100.0%50.0M0.00
Current lease liability23.2M-0.3%23.3M+4.1%22.4M+16.0%19.3M+18.4%16.3M+2.4%
Other current liabilities52.8M-1.5%53.6M+32.6%40.4M-14.9%47.5M+72.2%27.6M+17.4%
1.52B+18.9%1.28B+16.2%1.10B+13.6%966M+36.6%707M+20.9%
Non-current lease liability114M-10.0%126M-11.2%142M+2.3%139M+6.0%131M+13.7%
Operating lease liability (total)137M-8.5%150M-9.1%164M+4.0%158M+7.4%147M+12.4%
Deferred tax liabilities1.35M-24.7%1.80M-25.1%2.40M+124.7%1.07M-0.9%1.08M-92.0%
Other non-current liabilities57.7M+34.9%42.7M+51.4%28.2M+24.3%22.7M+27.9%17.7M+10.3%
459M-44.4%826M+47.7%559M+44.7%386M-59.5%953M+18.3%
Preferred stock0.000.000.000.000.00
Common stock284K-7.2%306K-0.6%308K-0.3%309K-14.2%360K+1.4%
Additional paid-in capital936M+10.9%844M+5.2%803M+4.1%771M+5.9%728M+4.6%
Retained earnings-460M-5732.2%8.17M+103.7%-222M+38.4%-360M-253.1%235M+103.9%
Treasury stock12.2M-0.6%12.2M-0.7%12.3M-1.4%12.5M+130.3%5.43M-2.7%
Accumulated other comprehensive income-4.91M+66.7%-14.7M-46.4%-10.1M+18.7%-12.4M-155.7%-4.85M-3599.2%
Total equity incl. non-controlling459M-44.4%826M+47.7%559M+44.7%386M-59.5%953M+18.3%
Total liabilities & equity1.98B-6.0%2.10B+26.8%1.66B+22.5%1.35B-18.5%1.66B+19.4%
Common shares issued28.4M-7.4%30.6M-0.4%30.8M-1.1%31.1M-13.7%36.0M+1.4%
Common shares outstanding28.4M-7.4%30.6M-0.4%30.8M-1.1%31.1M-13.7%36.0M+1.4%
Shares outstanding (cover)28.4M-6.8%30.5M-1.0%30.8M-0.9%31.1M-11.9%35.2M-1.4%
Treasury shares69.6K-0.6%70.1K-0.7%70.6K-1.4%71.6K-60.2%180K-2.7%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
713M+17.1%609M+40.5%433M+11.7%388M+47.4%263M+1.8%
Depreciation & amortization28.1M-3.9%29.3M+11.1%26.3M+17.8%22.3M+5.8%21.1M+8.1%
Intangible amortization946K-34.4%1.44M-34.4%2.20M-34.4%3.35M-34.5%5.11M-35.1%
Share-based compensation34.8M+36.3%25.5M+24.4%20.5M-4.2%21.4M+48.0%14.5M+5.0%
Deferred income taxes80.9M+403.8%-26.6M-6.0%-25.1M-9.1%-23.0M+38.0%-37.1M-7142.1%
Change in payables2.63M+188.7%-2.96M-382.1%1.05M-83.7%6.43M+244.6%1.87M+171.9%
-31.1M-10.0%-28.3M+18.3%-34.6M+10.6%-38.7M-23.5%-31.4M-0.5%
Capital expenditure31.4M-14.2%36.5M-0.3%36.6M-0.6%36.9M+30.4%28.3M-9.8%
Free cash flow682M+19.2%572M+44.2%397M+13.0%351M+49.4%235M+3.4%
Acquisitions0.000.000.000.000.00
Other investing activities-216K+97.4%-8.24M-308.1%-2.02M-208.4%1.86M-39.8%3.09M+2554.8%
-860M-458.7%-154M+15.7%-183M+76.5%-776M-1645.2%-44.5M+46.0%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased917M+440.1%170M+17.9%144M-83.0%848M+1265.4%62.1M-36.8%
Dividends paid0.000.000.000.000.00
FX effect on cash5.92M+335.7%-2.51M-332.3%1.08M+116.4%-6.57M-65.5%-3.97M-696.4%
Net change in cash-172M-140.7%424M+95.2%217M+150.2%-433M-335.9%184M+25.8%
Interest paid0.00-100.0%171K-94.4%3.06M+4.1%2.94M+2286.2%123K+18.3%
Income taxes paid39.7M-52.5%83.6M+9.4%76.4M+52.2%50.2M-10.8%56.2M+143.4%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap15.9B+56.6%10.2B+8.2%9.41B+42.4%6.61B-15.7%7.84B+58.5%
P/E35.3×+40.4%25.2×-26.9%34.4×+18.2%29.1×-32.4%43.1×+26.7%
P/S6.3×+30.5%4.8×-8.6%5.3×+9.8%4.8×-29.9%6.9×+28.5%
P/B34.7×+181.6%12.3×-38.3%20.0×+5.8%18.9×+129.6%8.2×+34.0%
P/FCF23.4×+31.4%17.8×-28.6%24.9×+7.6%23.1×-30.6%33.3×+53.3%
Earnings yield2.8%-28.8%4.0%+36.8%2.9%-15.4%3.4%+47.9%2.3%-21.1%
FCF yield4.3%-23.9%5.6%+40.0%4.0%-7.1%4.3%+44.1%3.0%-34.8%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025August J. Troendle$11.4M$11.7M$2.2M$403.48$99.39
FY2024—$8.6M$17.7M$4.2M$238.67$81.07
FY2023—$1.6M$9.3M$918.6K$220.21$81.77
FY2022—$1.9M$12.9M$1M$152.59$76.75
FY2021—$5.9M$7.7M$2M$156.35$96.45
FY2020—$4.1M$6M$1.8M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: MEDP’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all MEDP filings on SEC EDGAR → Not investment advice.